{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:33:50Z","timestamp":1790004830985,"version":"4.0.1"},"reference-count":110,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Ischemia-reperfusion injury (IRI) is an unavoidable consequence of kidney transplantation and a major contributor to delayed graft function (DGF). DGF, traditionally defined as the need for dialysis within the first week post-transplant, is linked to inferior graft and patient outcomes, prolonged hospitalization, and higher health care costs. IRI begins with tissue hypoxia, which triggers an inflammatory response on reperfusion. The renal tubule plays a critical role in complement synthesis, with local activation driving inflammation and graft immunogenicity more than circulating liver-derived complement. The lectin pathway is a key initiator of complement activation in hypoxic renal tubules, primarily through collectin-11's interaction with glycan ligands on hypoxic cells, with further amplification through the alternative pathway. Despite promising preclinical results, systemic complement inhibitors have not significantly improved DGF in clinical studies, likely due to inefficient targeting of ischemic renal tubules. Machine perfusion offers a novel approach to delivering therapeutics directly to donor kidneys. Notably, hypothermic machine perfusion has improved DGF rates and early graft outcomes. Emerging targeted delivery systems using extracellular vesicles or nanoparticle-based carriers also promise to deliver therapeutics to the sites of injury. Organ-targeted complement inhibition through machine perfusion or other targeted delivery systems represent compelling strategies for IRI prevention. Finally, multigenic xenografts engineered to prevent complement activation have shown initial promise in overcoming the complement-mediated barriers that continue to challenge allotransplantation in humans.<\/jats:p>","DOI":"10.1681\/asn.0000000826","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:01:31Z","timestamp":1753200091000},"page":"193-207","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5417-8686","authenticated-orcid":false,"given":"Chrysanthos D.","family":"Christou","sequence":"first","affiliation":[{"name":"Directorate of Transplant, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2017-375X","authenticated-orcid":false,"given":"Fayyad","family":"Jaradat","sequence":"additional","affiliation":[{"name":"Directorate of Transplant, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9127-8950","authenticated-orcid":false,"given":"Jonathon","family":"Olsburgh","sequence":"additional","affiliation":[{"name":"Directorate of Transplant, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Sacks","sequence":"additional","affiliation":[{"name":"Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-1278","authenticated-orcid":false,"given":"Theodoros","family":"Kassimatis","sequence":"additional","affiliation":[{"name":"Directorate of Transplant, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"},{"name":"Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom"},{"name":"King's Kidney Care, King's College Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"2","key":"B1-20260717","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.kint.2019.02.009","article-title":"Regulated necrosis in kidney ischemia-reperfusion injury","volume":"96","author":"Pefanis","year":"2019","journal-title":"Kidney Int."},{"issue":"11","key":"B2-20260717","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","article-title":"Cellular pathophysiology of ischemic acute kidney injury","volume":"121","author":"Bonventre","year":"2011","journal-title":"J Clin Invest."},{"issue":"9447","key":"B3-20260717","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(04)17406-0","article-title":"Delayed graft function in kidney transplantation","volume":"364","author":"Perico","year":"2004","journal-title":"Lancet."},{"issue":"3","key":"B4-20260717","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/j.ajkd.2008.06.005","article-title":"A systematic review of kidney transplantation from expanded criteria donors","volume":"52","author":"Pascual","year":"2008","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"B5-20260717","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1600-6143.2007.01852.x","article-title":"Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation","volume":"7","author":"Locke","year":"2007","journal-title":"Am J Transplant."},{"issue":"1","key":"B6-20260717","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12882-022-02777-9","article-title":"Duration of delayed graft function and its impact on graft outcomes in deceased donor kidney transplantation","volume":"23","author":"Budhiraja","year":"2022","journal-title":"BMC Nephrol."},{"issue":"2","key":"B7-20260717","doi-asserted-by":"crossref","first-page":"e1433","DOI":"10.1097\/TXD.0000000000001433","article-title":"Effects of delayed graft function on transplant outcomes: a meta-analysis","volume":"9","author":"Li","year":"2023","journal-title":"Transplant Direct."},{"issue":"5","key":"B8-20260717","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/TP.0000000000000450","article-title":"Center-level variation in the development of delayed graft function after deceased donor kidney transplantation","volume":"99","author":"Orandi","year":"2015","journal-title":"Transplantation."},{"issue":"10","key":"B10-20260717","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.1111\/ctr.14022","article-title":"Financial impact of delayed graft function in kidney transplantation","volume":"34","author":"Kim","year":"2020","journal-title":"Clin Transplant."},{"issue":"3","key":"B11-20260717","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ndt\/gfn667","article-title":"Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis","volume":"24","author":"Yarlagadda","year":"2009","journal-title":"Nephrol Dial Transplant."},{"issue":"suppl 3","key":"B12-20260717","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant."},{"issue":"7","key":"B13-20260717","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/TP.0000000000004033","article-title":"Complications of percutaneous kidney allograft biopsy: systematic review and meta-analysis","volume":"106","author":"Ho","year":"2022","journal-title":"Transplantation."},{"issue":"6","key":"B14-20260717","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/SLA.0b013e3181a38f45","article-title":"Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies","volume":"249","author":"Diepenhorst","year":"2009","journal-title":"Ann Surg."},{"issue":"8","key":"B15-20260717","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1681\/ASN.2008111145","article-title":"Expression of complement components differs between kidney allografts from living and deceased donors","volume":"20","author":"Naesens","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B16-20260717","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1096\/fj.05-4747com","article-title":"Local extravascular pool of C3 is a determinant of postischemic acute renal failure","volume":"20","author":"Farrar","year":"2006","journal-title":"FASEB J."},{"issue":"5","key":"B17-20260717","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1172\/JCI83000","article-title":"Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury","volume":"126","author":"Farrar","year":"2016","journal-title":"J Clin Invest."},{"issue":"2","key":"B18-20260717","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0002-9440(10)63839-4","article-title":"Role for the alternative complement pathway in ischemia\/reperfusion injury","volume":"162","author":"Stahl","year":"2003","journal-title":"Am J Pathol."},{"issue":"5","key":"B19-20260717","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0002-9440(10)63424-4","article-title":"The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury","volume":"165","author":"de Vries","year":"2004","journal-title":"Am J Pathol."},{"issue":"10","key":"B20-20260717","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.imbio.2016.05.004","article-title":"Role of the lectin complement pathway in kidney transplantation","volume":"221","author":"Farrar","year":"2016","journal-title":"Immunobiology."},{"issue":"9","key":"B21-20260717","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1096\/fj.13-246306","article-title":"Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4","volume":"28","author":"Asgari","year":"2014","journal-title":"FASEB J."},{"issue":"3","key":"B22-20260717","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.170.3.1517","article-title":"Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice","volume":"170","author":"Thurman","year":"2003","journal-title":"J Immunol."},{"issue":"1","key":"B23-20260717","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13063-017-1972-x","article-title":"A double-blind randomised controlled investigation into the efficacy of mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial","volume":"18","author":"Kassimatis","year":"2017","journal-title":"Trials."},{"issue":"3","key":"B24-20260717","doi-asserted-by":"crossref","first-page":"e097029","DOI":"10.1136\/bmjopen-2024-097029","article-title":"Multicentre, multi-arm, double-blind randomised placebo-controlled dose-finding trial investigating the safety and efficacy of MirococePt (APT070) in reducing delayed graft function in the kidney ALlograft (EMPIRIKAL-2): study protocol for a randomised controlled trial","volume":"15","author":"Kassimatis","year":"2025","journal-title":"BMJ Open."},{"issue":"5","key":"B26-20260717","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/cells12050791","article-title":"The complement system in kidney transplantation","volume":"12","author":"Santarsiero","year":"2023","journal-title":"Cells."},{"issue":"9","key":"B27-20260717","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1681\/ASN.2017010079","article-title":"Complement recognition pathways in renal transplantation","volume":"28","author":"Nauser","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B28-20260717","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4049\/jimmunol.176.6.3330","article-title":"Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype","volume":"176","author":"Peng","year":"2006","journal-title":"J Immunol."},{"issue":"10","key":"B29-20260717","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol."},{"issue":"5","key":"B30-20260717","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hc0502.102867","article-title":"No-reflow phenomenon","volume":"105","author":"Rezkalla","year":"2002","journal-title":"Circulation."},{"issue":"2","key":"B31-20260717","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5500\/wjt.v5.i2.52","article-title":"Update on ischemia-reperfusion injury in kidney transplantation: pathogenesis and treatment","volume":"5","author":"Salvadori","year":"2015","journal-title":"World J Transplant."},{"key":"B32-20260717","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2016.11.004","article-title":"Complement-mediated inflammation and injury in brain dead organ donors","volume":"84","author":"Poppelaars","year":"2017","journal-title":"Mol Immunol."},{"issue":"4","key":"B33-20260717","doi-asserted-by":"crossref","first-page":"152396","DOI":"10.1016\/j.imbio.2023.152396","article-title":"Complement activation and kidney transplantation; a complex relationship","volume":"228","author":"Gibson","year":"2023","journal-title":"Immunobiology."},{"issue":"7","key":"B34-20260717","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1093\/ndt\/gfq717","article-title":"Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation","volume":"26","author":"Damman","year":"2011","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B35-20260717","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1600-6143.2011.03466.x","article-title":"Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation","volume":"11","author":"de Vries","year":"2011","journal-title":"Am J Transplant."},{"issue":"10","key":"B36-20260717","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1111\/ajt.16574","article-title":"Effect of delayed graft function on longer-term outcomes after kidney transplantation from donation after circulatory death donors in the United Kingdom: a national cohort study","volume":"21","author":"Phillips","year":"2021","journal-title":"Am J Transplant."},{"issue":"5","key":"B37-20260717","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/SLA.0000000000003515","article-title":"The neglectable impact of delayed graft function on long-term graft survival in kidneys donated after circulatory death associates with superior organ resilience","volume":"270","author":"de Kok","year":"2019","journal-title":"Ann Surg."},{"issue":"4","key":"B38-20260717","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1681\/ASN.2005101116","article-title":"Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage","volume":"17","author":"Patel","year":"2006","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B39-20260717","doi-asserted-by":"crossref","first-page":"F1174","DOI":"10.1152\/ajprenal.00670.2020","article-title":"Aberrant activation of the complement system in renal grafts is mediated by cold storage","volume":"320","author":"Lo","year":"2021","journal-title":"Am J Physiol Renal Physiol."},{"issue":"9","key":"B40-20260717","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/ajt.13797","article-title":"Targeting complement pathways during cold ischemia and reperfusion prevents delayed graft function","volume":"16","author":"Yu","year":"2016","journal-title":"Am J Transplant."},{"issue":"1","key":"B41-20260717","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1038\/s41598-021-94954-3","article-title":"Multiplex gene analysis reveals T-cell and antibody-mediated rejection-specific upregulation of complement in renal transplants","volume":"11","author":"Vonbrunn","year":"2021","journal-title":"Sci Rep."},{"issue":"9","key":"B42-20260717","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2011111072","article-title":"C3a and C5a promote renal ischemia-reperfusion injury","volume":"23","author":"Peng","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B43-20260717","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.170.7.3883","article-title":"Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils","volume":"170","author":"de Vries","year":"2003","journal-title":"J Immunol."},{"issue":"1","key":"B44-20260717","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2008.08.016","article-title":"The innate immune response in ischemic acute kidney injury","volume":"130","author":"Jang","year":"2009","journal-title":"Clin Immunol."},{"issue":"4","key":"B45-20260717","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/ckj\/sfaa147","article-title":"Activation of final complement components after kidney transplantation as a marker of delayed graft function severity","volume":"14","author":"Arias-Cabrales","year":"2021","journal-title":"Clin Kidney J."},{"issue":"3","key":"B46-20260717","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00007890-200002150-00017","article-title":"Activation of inflammatory mediators in rat renal isografts by donor brain death","volume":"69","author":"Kusaka","year":"2000","journal-title":"Transplantation."},{"issue":"4","key":"B47-20260717","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2353\/ajpath.2010.090276","article-title":"Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage","volume":"176","author":"Castellano","year":"2010","journal-title":"Am J Pathol."},{"issue":"5","key":"B48-20260717","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1084\/jem.183.5.2343","article-title":"Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement","volume":"183","author":"Weiser","year":"1996","journal-title":"J Exp Med."},{"issue":"8","key":"B49-20260717","doi-asserted-by":"crossref","first-page":"e0183701","DOI":"10.1371\/journal.pone.0183701","article-title":"Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice","volume":"12","author":"Danobeitia","year":"2017","journal-title":"PLoS One."},{"issue":"7","key":"B50-20260717","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.4049\/jimmunol.1202275","article-title":"Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice","volume":"190","author":"Miwa","year":"2013","journal-title":"J Immunol."},{"issue":"5","key":"B51-20260717","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-3083.2005.01591.x","article-title":"Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury","volume":"61","author":"M\u00f8ller-Kristensen","year":"2005","journal-title":"Scand J Immunol."},{"issue":"18","key":"B52-20260717","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1073\/pnas.1101748108","article-title":"Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia\/reperfusion injury","volume":"108","author":"Schwaeble","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"B53-20260717","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1096\/fj.201901582R","article-title":"l\u2010Fucose prevention of renal ischaemia\/reperfusion injury in mice","volume":"34","author":"Howard","year":"2020","journal-title":"FASEB J."},{"issue":"3","key":"B54-20260717","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol."},{"issue":"4","key":"B55-20260717","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.2014.168","article-title":"Complement activation in the tubulointerstitium: AKI, CKD, and in between","volume":"86","author":"Brar","year":"2014","journal-title":"Kidney Int."},{"issue":"12","key":"B56-20260717","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.4049\/jimmunol.1601943","article-title":"Overexpression of human CD55 and CD59 or treatment with human CD55 protects against renal ischemia-reperfusion injury in mice","volume":"198","author":"Bongoni","year":"2017","journal-title":"J Immunol."},{"issue":"6","key":"B57-20260717","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.172.6.3869","article-title":"Critical protection from renal ischemia reperfusion injury by CD55 and CD59","volume":"172","author":"Yamada","year":"2004","journal-title":"J Immunol."},{"issue":"2","key":"B58-20260717","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI24521","article-title":"Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia\/reperfusion","volume":"116","author":"Thurman","year":"2006","journal-title":"J Clin Invest."},{"issue":"8","key":"B59-20260717","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00467-018-4042-z","article-title":"The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?","volume":"34","author":"Michels","year":"2019","journal-title":"Pediatr Nephrol."},{"issue":"9","key":"B60-20260717","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/ajt.14262","article-title":"Complement alternative pathway deficiency in recipients protects kidney allograft from ischemia\/reperfusion injury and alloreactive T cell response","volume":"17","author":"Casiraghi","year":"2017","journal-title":"Am J Transplant."},{"issue":"26","key":"B61-20260717","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.0801015105","article-title":"The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis","volume":"105","author":"Kemper","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"B62-20260717","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.4049\/jimmunol.180.11.7613","article-title":"Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation","volume":"180","author":"Xu","year":"2008","journal-title":"J Immunol."},{"issue":"4","key":"B63-20260717","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/ki.2014.103","article-title":"Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia\u2013reperfusion injury","volume":"86","author":"Miao","year":"2014","journal-title":"Kidney Int."},{"issue":"5","key":"B64-20260717","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/eji.201747240","article-title":"Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM","volume":"48","author":"Goetz","year":"2018","journal-title":"Eur J Immunol."},{"issue":"12","key":"B65-20260717","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1111\/ajt.14767","article-title":"A phase I\/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients","volume":"18","author":"Jordan","year":"2018","journal-title":"Am J Transplant."},{"issue":"1","key":"B66-20260717","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2215\/CJN.04840419","article-title":"Three-year outcomes of a randomized, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients","volume":"15","author":"Huang","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B69-20260717","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ajt.15580","article-title":"Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: results of two randomized controlled pilot trials","volume":"20","author":"Schr\u00f6ppel","year":"2020","journal-title":"Am J Transplant."},{"issue":"2","key":"B70-20260717","doi-asserted-by":"crossref","first-page":"e13129","DOI":"10.1111\/petr.13129","article-title":"A prospective randomized, controlled trial of eculizumab to prevent ischemia-reperfusion injury in pediatric kidney transplantation","volume":"22","author":"Kaabak","year":"2018","journal-title":"Pediatr Transplant."},{"issue":"6","key":"B71-20260717","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/prep.1995.0003","article-title":"Overexpression in Escherichia coli, folding, purification, and characterization of the first three short consensus repeat modules of human complement receptor type 1","volume":"6","author":"Dodd","year":"1995","journal-title":"Protein Expr Purif."},{"issue":"3","key":"B72-20260717","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/ajt.16265","article-title":"Ex vivo delivery of mirococept: a dose-finding study in pig kidney after showing a low dose is insufficient to reduce delayed graft function in human kidney","volume":"21","author":"Kassimatis","year":"2021","journal-title":"Am J Transplant."},{"issue":"4","key":"B73-20260717","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jaci.2020.08.028","article-title":"ARGX-117, a therapeutic complement inhibiting antibody targeting C2","volume":"147","author":"Van de Walle","year":"2021","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"B75-20260717","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-019-01068-2","article-title":"Ravulizumab: first global approval","volume":"79","author":"McKeage","year":"2019","journal-title":"Drugs."},{"issue":"6","key":"B76-20260717","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00415-023-11617-1","article-title":"Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis","volume":"270","author":"Vu","year":"2023","journal-title":"J Neurol."},{"issue":"6","key":"B77-20260717","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","article-title":"Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study","volume":"133","author":"Lee","year":"2019","journal-title":"Blood."},{"issue":"2","key":"B79-20260717","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/ajt.16868","article-title":"Preclinical models versus clinical renal ischemia reperfusion injury: a systematic review based on metabolic signatures","volume":"22","author":"Lerink","year":"2022","journal-title":"Am J Transplant."},{"issue":"5","key":"B80-20260717","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MOT.0000000000001003","article-title":"Normothermic machine perfusion of kidneys: current strategies and future perspectives","volume":"27","author":"Messner","year":"2022","journal-title":"Curr Opin Organ Transplant."},{"key":"B81-20260717","doi-asserted-by":"crossref","first-page":"850271","DOI":"10.3389\/fimmu.2022.850271","article-title":"Kidney normothermic machine perfusion can be used as a preservation technique and a model of reperfusion to deliver novel therapies and assess inflammation and immune activation","volume":"13","author":"Mellati","year":"2022","journal-title":"Front Immunol."},{"issue":"7","key":"B82-20260717","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ajt.2024.01.001","article-title":"Utilizing pathophysiological concepts of ischemia-reperfusion injury to design renoprotective strategies and therapeutic interventions for normothermic ex vivo kidney perfusion","volume":"24","author":"Ogurlu","year":"2024","journal-title":"Am J Transplant."},{"issue":"5","key":"B83-20260717","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3390\/jcm12051787","article-title":"How to best protect kidneys for transplantation\u2014mechanistic target","volume":"12","author":"Akalay","year":"2023","journal-title":"J Clin Med."},{"issue":"4","key":"B84-20260717","doi-asserted-by":"crossref","first-page":"e13814","DOI":"10.1111\/ctr.13814","article-title":"Hypothermic machine perfusion is superior to static cold storage in deceased donor kidney transplantation: a meta\u2010analysis","volume":"34","author":"Tingle","year":"2020","journal-title":"Clin Transplant."},{"issue":"3 suppl","key":"B85-20260717","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.cryobiol.2009.06.004","article-title":"Hypothermic organ preservation by static storage methods: current status and a view to the future","volume":"60","author":"McAnulty","year":"2010","journal-title":"Cryobiology."},{"issue":"1","key":"B86-20260717","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1038\/s41598-020-63687-0","article-title":"Pharmacologic targeting of renal ischemia-reperfusion injury using a normothermic machine perfusion platform","volume":"10","author":"Hameed","year":"2020","journal-title":"Sci Rep."},{"issue":"3","key":"B87-20260717","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bph.16220","article-title":"Targeted delivery of galunisertib using machine perfusion reduces fibrogenesis in an integrated ex vivo renal transplant and fibrogenesis model","volume":"181","author":"van Leeuwen","year":"2024","journal-title":"Br J Pharmacol."},{"issue":"7","key":"B88-20260717","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/ajt.16473","article-title":"Mesenchymal stromal cell treatment of donor kidneys during ex vivo normothermic machine perfusion: a porcine renal autotransplantation study","volume":"21","author":"Lohmann","year":"2021","journal-title":"Am J Transplant."},{"issue":"14","key":"B89-20260717","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.3390\/ijms20143607","article-title":"Infusing mesenchymal stromal cells into porcine kidneys during normothermic machine perfusion: intact MSCs can be traced and localised to glomeruli","volume":"20","author":"Pool","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"4","key":"B90-20260717","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/ajt.16929","article-title":"MicroRNA antagonist therapy during normothermic machine perfusion of donor kidneys","volume":"22","author":"Thompson","year":"2022","journal-title":"Am J Transplant."},{"issue":"10","key":"B91-20260717","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1681\/ASN.2020111561","article-title":"Kim-1 targeted extracellular vesicles: a new therapeutic platform for RNAi to treat AKI","volume":"32","author":"Tang","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B92-20260717","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41467-025-56223-z","article-title":"High-density lipoprotein nanoparticles spontaneously target to damaged renal tubules and alleviate renal fibrosis by remodeling the fibrotic niches","volume":"16","author":"He","year":"2025","journal-title":"Nat Commun."},{"issue":"12","key":"B93-20260717","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1111\/jcmm.13249","article-title":"Perfusion of isolated rat kidney with mesenchymal stromal cells\/extracellular vesicles prevents ischaemic injury","volume":"21","author":"Gregorini","year":"2017","journal-title":"J Cell Mol Med."},{"issue":"1","key":"B94-20260717","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13287-017-0727-7","article-title":"Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges","volume":"8","author":"Aghajani","year":"2017","journal-title":"Stem Cell Res Ther."},{"issue":"418","key":"B95-20260717","doi-asserted-by":"crossref","first-page":"eaam6764","DOI":"10.1126\/scitranslmed.aam6764","article-title":"Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys","volume":"9","author":"Tietjen","year":"2017","journal-title":"Sci Transl Med."},{"issue":"19","key":"B96-20260717","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa2412747","article-title":"Xenotransplantation of a porcine kidney for end-stage kidney disease","volume":"392","author":"Kawai","year":"2025","journal-title":"New Engl J Med."},{"issue":"2","key":"B97-20260717","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00007890-199108000-00006","article-title":"Immunopathology of hyperacute xenograft rejection in a swine-to-primate model","volume":"52","author":"Platt","year":"1991","journal-title":"Transplantation."},{"issue":"7","key":"B98-20260717","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00007890-200204150-00024","article-title":"Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors","volume":"73","author":"Schuurman","year":"2002","journal-title":"Transplantation."},{"issue":"7982","key":"B99-20260717","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation","volume":"622","author":"Anand","year":"2023","journal-title":"Nature."},{"issue":"1","key":"B100-20260717","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1038\/s41467-024-47679-6","article-title":"Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs","volume":"15","author":"Eisenson","year":"2024","journal-title":"Nat Commun."},{"issue":"4","key":"B101-20260717","doi-asserted-by":"crossref","first-page":"e12881","DOI":"10.1111\/xen.12881","article-title":"Production of four-gene (GTKO\/hCD55\/hTBM\/hCD39)-edited donor pigs and kidney xenotransplantation","volume":"31","author":"Yang","year":"2024","journal-title":"Xenotransplantation."},{"issue":"8","key":"B102-20260717","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/ajt.15329","article-title":"Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion","volume":"19","author":"Kim","year":"2019","journal-title":"Am J Transplant."},{"issue":"20","key":"B103-20260717","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa2120238","article-title":"Results of two cases of pig-to-human kidney xenotransplantation","volume":"386","author":"Montgomery","year":"2022","journal-title":"New Engl J Med."},{"key":"B104-20260717","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2018.00705","article-title":"High-mobility group box 1-induced complement activation causes sterile inflammation","volume":"9","author":"Kim","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"B105-20260717","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1379\/1466-1268(2002)007<0017:HSPIAP>2.0.CO;2","article-title":"Heat shock protein 70 is a potent activator of the human complement system","volume":"7","author":"Proh\u00e1szka","year":"2002","journal-title":"Cell Stress Chaperones."},{"issue":"3","key":"B106-20260717","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/emboj\/21.3.231","article-title":"The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex","volume":"21","author":"Budayova-Spano","year":"2002","journal-title":"EMBO J."},{"issue":"10","key":"B107-20260717","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI8621","article-title":"Predominant role for C5b-9 in renal ischemia\/reperfusion injury","volume":"105","author":"Zhou","year":"2000","journal-title":"J Clin Invest."},{"issue":"1","key":"B108-20260717","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1523-1755.2003.00737.x","article-title":"A small molecule C5a receptor antagonist protects kidneys from ischemia\/reperfusion injury in rats","volume":"63","author":"Arumugam","year":"2003","journal-title":"Kidney Int."},{"issue":"3","key":"B109-20260717","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.4049\/jimmunol.178.3.1819","article-title":"C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia\/reperfusion","volume":"178","author":"Thurman","year":"2007","journal-title":"J Immunol."},{"key":"B110-20260717","doi-asserted-by":"crossref","first-page":"811696","DOI":"10.3389\/fimmu.2022.811696","article-title":"Role of complement system in kidney transplantation: stepping from animal models to clinical application","volume":"13","author":"Qi","year":"2022","journal-title":"Front Immunol."},{"issue":"8","key":"B111-20260717","doi-asserted-by":"crossref","first-page":"F801","DOI":"10.1152\/ajprenal.00469.2013","article-title":"Role of toll-like receptor-4 in renal graft ischemia-reperfusion injury","volume":"306","author":"Zhao","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"B112-20260717","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40472-014-0017-6","article-title":"Ischemia\/reperfusion injury and its consequences on immunity and inflammation","volume":"1","author":"Slegtenhorst","year":"2014","journal-title":"Curr Transpl Rep."},{"issue":"2","key":"B113-20260717","doi-asserted-by":"crossref","first-page":"C460","DOI":"10.1152\/ajpcell.00211.2007","article-title":"Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria","volume":"294","author":"Chen","year":"2008","journal-title":"Am J Physiol Cell Physiol."},{"issue":"6","key":"B114-20260717","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/11201100-000000000-00000","article-title":"Human C1-esterase inhibitor concentrate (berinert)","volume":"23","author":"Keating","year":"2009","journal-title":"BioDrugs."},{"issue":"6","key":"B115-20260717","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/MOT.0000000000000249","article-title":"Eculizumab use in kidney transplantation","volume":"20","author":"Johnson","year":"2015","journal-title":"Curr Opin Organ Transplant."},{"issue":"4","key":"B116-20260717","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0002-9440(10)63503-1","article-title":"Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia\/reperfusion damage, acute rejection, and chronic nephropathy","volume":"163","author":"Pratt","year":"2003","journal-title":"Am J Pathol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:49:28Z","timestamp":1786132168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000000826","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]}}}